A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Teens age 16 through 18 years can get the booster dose at any time. The minimum interval between doses is 8 weeks. However, teens who receive their first dose of quadrivalent meningococcal conjugate vaccine at or after age 16 do not need a booster dose.ll 11â12 year olds should be vaccinated with a quadrivalent (protects against serogroups A, C, W, and Y) meningococcal conjugate vaccine (MenactraÂ® or MenveoÂ®). A booster dose is recommended at age 16 years.